A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience

A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience

Biologic drugs (e.g. anti-tumor necrosis factors) are effective treatments for multiple chronic inflammatory diseases including rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. Administration of biologic drugs is usually via subcutaneous self-injection, which provides many pat...

Full description

Bibliographic Details
Main Authors: Bart J. F. van den Bemt, Lynda Gettings, Barbara Domańska, Richard Bruggraber, Irina Mountian, Lars E. Kristensen
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Drug Delivery
Subjects:
anti-tnf
electronic injection device
pre-filled pen
pre-filled syringe
self-injection
Online Access:http://dx.doi.org/10.1080/10717544.2019.1587043

Similar Items

Similar Items